JP2024532787A5 - - Google Patents

Info

Publication number
JP2024532787A5
JP2024532787A5 JP2024508568A JP2024508568A JP2024532787A5 JP 2024532787 A5 JP2024532787 A5 JP 2024532787A5 JP 2024508568 A JP2024508568 A JP 2024508568A JP 2024508568 A JP2024508568 A JP 2024508568A JP 2024532787 A5 JP2024532787 A5 JP 2024532787A5
Authority
JP
Japan
Prior art keywords
liposomes
effective amount
administration
weeks
tau
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532787A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074902 external-priority patent/WO2023019241A2/en
Publication of JP2024532787A publication Critical patent/JP2024532787A/ja
Publication of JP2024532787A5 publication Critical patent/JP2024532787A5/ja
Pending legal-status Critical Current

Links

JP2024508568A 2021-08-12 2022-08-12 持続的な免疫応答を誘導するためのリン酸化タウペプチドを含むリポソーム Pending JP2024532787A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163260227P 2021-08-12 2021-08-12
US63/260,227 2021-08-12
US202163263541P 2021-11-04 2021-11-04
US63/263,541 2021-11-04
US202263267975P 2022-02-14 2022-02-14
US63/267,975 2022-02-14
PCT/US2022/074902 WO2023019241A2 (en) 2021-08-12 2022-08-12 Liposomes containing phosphorylated tau peptides for inducing sustained immune responses

Publications (2)

Publication Number Publication Date
JP2024532787A JP2024532787A (ja) 2024-09-10
JP2024532787A5 true JP2024532787A5 (enExample) 2025-08-19

Family

ID=85201019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508568A Pending JP2024532787A (ja) 2021-08-12 2022-08-12 持続的な免疫応答を誘導するためのリン酸化タウペプチドを含むリポソーム

Country Status (11)

Country Link
US (3) US20250134973A1 (enExample)
EP (1) EP4384216A4 (enExample)
JP (1) JP2024532787A (enExample)
KR (1) KR20240042508A (enExample)
AU (1) AU2022328342A1 (enExample)
CA (1) CA3228878A1 (enExample)
CL (1) CL2024000408A1 (enExample)
IL (1) IL310761A (enExample)
JO (1) JOP20240028A1 (enExample)
MX (1) MX2024001906A (enExample)
WO (1) WO2023019241A2 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106390107B (zh) * 2009-06-10 2019-12-31 纽约大学 病理tau蛋白的免疫靶向
CN111787942B (zh) * 2017-10-25 2024-03-29 杨森制药公司 磷酸化Tau肽的组合物及其用途
MY206596A (en) * 2019-02-08 2024-12-25 Janssen Pharmaceuticals Inc Method of safe administration of phosphorylated tau peptide vaccine
JOP20210284A1 (ar) * 2019-04-24 2023-01-30 Janssen Pharmaceuticals Inc الإعطاء غير المتجانس للقاحات تاو

Similar Documents

Publication Publication Date Title
TWI868106B (zh) 安全投予磷酸化Tau胜肽疫苗的方法
JP2022520060A5 (enExample)
TWI827557B (zh) Ｔａｕ胜肽之組成物及其用途
US11591377B2 (en) Heterologous administration of tau vaccines
US20230218730A1 (en) Vaccine therapy for ran protein diseases
US20110076323A1 (en) Vaccine for alzheimer's disease
JP2024532787A5 (enExample)
US20250170236A1 (en) A novel cationic adjuvant composition
JPWO2016080540A1 (ja) Ｄｎａ−ペプチド併用ワクチン
CA3230300A1 (en) Methods for the prevention and treatment of synucleinopathies
US20250144212A1 (en) Liposomes containing phosphorylated tau peptides for inducing sustained immune responses
JP2024538615A5 (enExample)
EA051841B1 (ru) Липосомы, содержащие фосфорилированные тау-пептиды, для индукции стойких иммунных ответов
HK40061379A (en) Method of safe administration of phosphorylated tau peptide vaccine
CN119894531A (zh) Tau肽免疫原构建体
CN118660717A (zh) 抗α-突触核蛋白的治疗性疫苗
EA045311B1 (ru) Способ безопасного введения вакцины фосфорилированного пептида tau
CN118613496A (zh) 安全施用Tau磷酸肽缀合物的方法
EA050855B1 (ru) ЛИПОСОМА ДЛЯ ПРИМЕНЕНИЯ В СПОСОБЕ ИНДУКЦИИ АНТИТЕЛ К ФОСФОРИЛИРОВАННОМУ ПЕПТИДУ Tau